Based on a protein microarray, that study reported that seven women with fetal DS in the 15th–18th weeks of gestation had increased plasma concentrations of one chemokine, CXCL7 (NAP-2), and decreased plasma concentrations of four chemokines, hemofiltrate CC chemokine 4 (HCC-4), interleukin 28A (IL-28A), interleukin 31 (IL-31), and monocyte chemotactic protein 2 (MCP-2). This evidence concerns the gene IFNL2 and Dravet syndrome.